Cargando…

Tailored immunosuppression after kidney transplantation - a single center real-life experience

BACKGROUND: Kidney allograft survival continuously improved with introduction of novel immunosuppressants. However, also immunologically challenging transplants (blood group incompatibility and sensitized recipients) increase. Between 2006 and 2008, a new tailored immunosuppression scheme for kidney...

Descripción completa

Detalles Bibliográficos
Autores principales:	Good-Weber, Miriam, Roos, Malgorzata, Mueller, Thomas F., Rüsi, Barbara, Fehr, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686677/ https://www.ncbi.nlm.nih.gov/pubmed/33228545 http://dx.doi.org/10.1186/s12882-020-02137-5

Ejemplares similares

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
por: Guthoff, Martina, et al.
Publicado: (2020)

Immunosuppression in kidney transplantation
por: MUNTEAN, ADRIANA, et al.
Publicado: (2013)

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore
por: Chang, Zi Yun, et al.
Publicado: (2021)

Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
por: Olaso, Danae, et al.
Publicado: (2021)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
por: Phanish, Mysore K., et al.
Publicado: (2020)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

Immunosuppressive Medication Adherence in Kidney Transplant Patients
por: Lalić, Jelena, et al.
Publicado: (2014)

Sebaceous adenoma in the setting of immunosuppression for kidney transplantation
por: Reinhart, Jacob, et al.
Publicado: (2019)

Immunosuppression-related neurological disorders in kidney transplantation
por: Faravelli, Irene, et al.
Publicado: (2021)

Psychological processing of a kidney transplantation, perceived quality of life, and immunosuppressant medication adherence
por: Scheel, Jennifer, et al.
Publicado: (2019)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients
por: Page, Timothy F., et al.
Publicado: (2008)

Cytomegalovirus infection in immunosuppressed patients after kidney transplantation
por: LUSCALOV, SIMONA, et al.
Publicado: (2016)

COVID-19: implications for immunosuppression in kidney disease and transplantation
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Covid-19 in kidney transplant recipients with immunosuppressive therapy
por: Sheikhalipour, Zahra, et al.
Publicado: (2022)

COVID-19 in kidney transplantation-implications for immunosuppression and vaccination
por: Kodali, Lavanya, et al.
Publicado: (2022)

Pattern and associated factors of adherence to immunosuppressive medications in kidney transplant recipients at a referral center in Iran
por: Moradi, Omid, et al.
Publicado: (2019)

The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir
por: Benner, Sarah E., et al.
Publicado: (2022)

The Peripheral NK Cell Repertoire after Kidney Transplantation is Modulated by Different Immunosuppressive Drugs
por: Neudoerfl, Christine, et al.
Publicado: (2013)

Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
por: Montero, Camilo, et al.
Publicado: (2022)

Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
por: Montero, Camilo, et al.
Publicado: (2023)

Immunosuppressive treatment and radiotherapy in kidney transplant patients: A systematic review
por: Lancellotta, Valentina, et al.
Publicado: (2022)

Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation
por: Singh, Namita, et al.
Publicado: (2018)

Biomarkers and a tailored approach for immune monitoring in kidney transplantation
por: Salcido-Ochoa, Francisco, et al.
Publicado: (2017)

Kidney Transplantation: Single-Center Experience
por: Sozener, Ulas, et al.
Publicado: (2020)

Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)
por: Girardin, François R., et al.
Publicado: (2023)

Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center
por: Chang, David H., et al.
Publicado: (2020)

Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy
por: Yang, Danwen, et al.
Publicado: (2019)

Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19
por: Anton Pampols, Paula, et al.
Publicado: (2021)

Nonadherence to immunosuppressives and treatment in kidney transplant: ADHERE BRAZIL Study
por: Marsicano-Souza, Elisa Oliveira, et al.
Publicado: (2021)

Innovative immunosuppression in kidney transplantation: A challenge for unmet needs
por: Salvadori, Maurizio, et al.
Publicado: (2022)

Kidney Transplantation, Immunosuppression and the Risk of Fracture: Clinical and Economic Implications
por: Kuppachi, Sarat, et al.
Publicado: (2022)

Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
por: Urzì Brancati, Valentina, et al.
Publicado: (2022)

Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study
por: Santangelo, Michele L., et al.
Publicado: (2015)

The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation
por: Kraus, Anna K., et al.
Publicado: (2016)

Real clinical impact of drug–drug interactions of immunosuppressants in transplant patients
por: Gago‐Sánchez, Ana Isabel, et al.
Publicado: (2021)

Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation
por: Toapanta, Néstor, et al.
Publicado: (2022)

Successful Pregnancy in a Kidney-Pancreas Transplanted Patient on LifeCycle Pharma Tacrolimus (LCPT)-Based Immunosuppression
por: Bösmüller, Claudia, et al.
Publicado: (2022)

Renal Outcomes of Liver Transplantation Recipients Receiving Standard Immunosuppression and Early Renal Sparing Immunosuppression: A Retrospective Single Center Study
por: Sharma, Pratima, et al.
Publicado: (2019)

Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning – A randomized controlled single center feasibility study
por: Wagner-Skacel, Jolana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5ivgjujhk4j5rg5e1roafftriu